RadNet (RDNT)

RadNet’s Imaging Center segment is the main operating platform. By running freestanding centers, the company participates in a healthcare market that is shaped by demand for accessible, lower-cost alternatives to hospital-based imaging. Its services are typically ordered by referring physicians and are used in areas such as oncology, orthopedics, neurology, cardiology, and women’s health. The model depends on center utilization, payer relationships, clinical quality, and the ability to manage equipment, staffing, and regulatory requirements across multiple locations.

The company also operates a Digital Health segment that develops clinical applications designed to improve image interpretation and workflow. These tools emphasize areas including breast, brain, prostate, and pulmonary diagnostics, where artificial intelligence and advanced analytics may help radiologists identify abnormalities, prioritize cases, and improve consistency.

RadNet’s distinguishing feature is the combination of a large outpatient imaging footprint with software-oriented diagnostic technology. That mix gives it exposure to both the steady demand for medical imaging and the longer-term shift toward AI-assisted healthcare decision-making.